A new trading day began on Tuesday, with Ensysce Biosciences Inc (NASDAQ: ENSC) stock price down -0.32% from the previous day of trading, before settling in for the closing price of $0.68. ENSC’s price has ranged from $0.14 to $2.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -10.06% over the last five years. Meanwhile, its annual earnings per share averaged 82.30%. With a float of $19.18 million, this company’s outstanding shares have now reached $19.57 million.
The firm has a total of 9 workers. Let’s measure their productivity. In terms of profitability, gross margin is -337.58%, operating margin of -629.33%, and the pretax margin is -790.68%.
Ensysce Biosciences Inc (ENSC) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ensysce Biosciences Inc is 2.00%, while institutional ownership is 26.61%.
Ensysce Biosciences Inc (ENSC) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.37 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.30% per share during the next fiscal year.
Ensysce Biosciences Inc (NASDAQ: ENSC) Trading Performance Indicators
Here are Ensysce Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.82, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Ensysce Biosciences Inc (ENSC)
Analysing the last 5-days average volume posted by the [Ensysce Biosciences Inc, ENSC], we can find that recorded value of 5.62 million was lower than the volume posted last year of 8.49 million. As of the previous 9 days, the stock’s Stochastic %D was 30.56%. Additionally, its Average True Range was 0.12.
During the past 100 days, Ensysce Biosciences Inc’s (ENSC) raw stochastic average was set at 64.13%, which indicates a significant increase from 37.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 153.02% in the past 14 days, which was lower than the 223.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3865, while its 200-day Moving Average is $0.5595. Now, the first resistance to watch is $0.7266. This is followed by the second major resistance level at $0.7754. The third major resistance level sits at $0.8087. If the price goes on to break the first support level at $0.6445, it is likely to go to the next support level at $0.6112. Now, if the price goes above the second support level, the third support stands at $0.5624.
Ensysce Biosciences Inc (NASDAQ: ENSC) Key Stats
With a market capitalization of 13.27 million, the company has a total of 13,871K Shares Outstanding. Currently, annual sales are 2,230 K while annual income is -10,610 K. The company’s previous quarter sales were 3,420 K while its latest quarter income was 660 K.
